MissionIR Articles
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches Animal Study to Evaluate Potential Therapeutic Effect of DehydraTECH-CBD on Dementia
Lexaria Bioscience has launched DEM-A22-1, its first-ever study to investigate whether its patented DehydraTECH(TM)-processed CBD may have therapeutic use against dementia The animal study will involve a total of 32 Long Evans rats and will…
-
MissionIRNewsBreaks – Vision Energy Corp. (VIHDD) Announces IBN as Corporate Communications Partner
Vision Energy (OTCQB: VIHDD), a forward-looking energy company developing carbon-reduced solutions for the commercial, industrial and transportation sectors, is partnering with InvestorBrandNetwork (“IBN”) for its corporate communications needs. IBN is a multifaceted financial news and…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Moves to Significantly Expand Land Position at Iska Iska
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced its entry into an option agreement to acquire the Mina Casiterita and Mina Hoyada properties, which collectively cover 14.75 km southwest and west of the…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has closed on a private placement with two healthcare-focused institutional investors. The placement included the sale…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Releases Q3 2022 Financial Report
Freight Technologies (NASDAQ: FRGT), a technology company based on its custom-developed Fr8App platform, which is powered by AI and machine learning and which offers a real-time portal for B2B cross-border shipping and domestic shipping within…
-
Correlate Infrastructure Partners Inc. (CIPI) Eyeing Big Net Gains Following the Enactment of the Inflation Reduction Act; Has Finalized M&A Plans Through Q2 2023 and Posted Revenue Jump
With the recently passed Inflation Reduction Act, Correlate looks to achieve significant net gains The company just posted a significant revenue bump from $236,690 in Q2 2022 to $2,313,577 in Q3 2022, plus shows project…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Releases Q3 2022 Earnings Report and Corporate Update, Plans Earnings Call
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has released its financial results and corporate update for the three- and nine-month periods ended Sept. 30, 2022. The Q3 report milestones include…
-
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Director of Communications and Investor Relations Presents at LD Micro Main Event
BiondVax summarizes collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen to discover and develop nanosized antibody (NanoAb) therapies that address underserved and growing markets, including COVID-19, psoriasis,…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Announces First European Dosing in Potentially Pivotal GBM Trial
The National Brain Tumor Society anticipates that more than 13,000 Americans will receive a GBM diagnosis during 2022, accounting for 49.1% of all primary malignant brain tumors CNS announced the first patient in Europe has…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO Discusses Vast Potential of Autonomous Technology in ‘Get Authentic’ Interview
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, was featured in Get Authentic with Marques Ogden, a podcast series delivering honest, unfiltered and real-time stories from legendary…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Focus on Dementia and Diabetes Featured in New Interview
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in an interview produced by PCG Digital Holdings LLC and published on NewMediaWire. John Docherty, Lexaria’s president and head of research,…
-
Vision Energy Corp. (VIHDD) Accelerates Efforts for Development of Pioneering Green Energy Terminal in North Sea Port of Vlissingen, the Netherlands
Vision Energy is in advanced stages of planning for construction and delivery of Northwestern Europe’s first import, storage and handling terminal designed exclusively for hydrogen carriers, renewable energy products and low-carbon fuels Vision Energy, through…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advancing Research of SPU-21 in Human Synovial Tissue
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Q3 2022 Earnings Call
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that it will host its third quarter 2022 earnings call via webcast at 4:30 p.m. ET on…
-
HeartBeam Inc. (NASDAQ: BEAT) Awarded Top Honors for Game-Changing Cardiovascular Tech Platform
BEAT named winner of the 2022 Cardiovascular Innovations (“CVI”) Innovation Summit and Shark Tank Competition Company’s presentation included an overview of its HeartBeam AIMI™ platform, which aids in more precise heart attack diagnosis HeartBeam is…
-
Cepton, Inc. (NASDAQ: CPTN) to Solidify Its Financial Position With $100 Million Investment from Koito; Forges Ahead Toward Mass-Market Deployment of Its Lidar Technology
Cepton signed binding agreement with established automotive lighting tier 1 supplier Koito for investment of $100 million to bolster its next stage of growth Agreement penned on October 27, 2022, marks the third investment from…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off First-Ever Study on DehydraTECH-CBD for the Potential Treatment of Diabetes
In November 2021, Lexaria laid out its plans for several new and ongoing R&D programs, among them hormone replacement, dementia, rheumatoid disease, and diabetes The company has since begun its DIAB-A22-1 study program on the…
-
EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is Powering a Clean Energy Future with Carbon-Negative RNG
RNG is considered carbon-neutral because it is derived from organic sources that produce methane emissions while decaying EverGen is developing Canadian RNG infrastructure with projects in British Columbia, Alberta, and Ontario EverGen’s expansion projects backed…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Treatment Poised to Provide Reprieve to Millions of Patients
Lexaria Bioscience Corp. (NASDAQ: LEXX) is developing a potential hypertension treatment with little to no side effects. “The treatment is created by processing cannabidiol (‘CBD’) using the company’s patented DehydraTECH(TM) drug delivery technology, which has…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Trusted by the Game’s Elite: Newton Golf Company Inc. (NASDAQ: NWTG) Reaches New Milestone
- MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Paves Way to Redefine Cardiac Care
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Leads U.S. Effort to Reduce REE Dependence with Transformative Technology
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Announces $1.74 Million Grant to Advance Nova Scotia Community Solar Projects, for Which PowerBank is Lead Developer
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Showcases New Products and Growth Strategy at Mid-States 2025 Rendezvous